Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MRTX

Mirati Therapeutics (MRTX) Stock Price, News & Analysis

Mirati Therapeutics logo

About Mirati Therapeutics Stock (NASDAQ:MRTX)

Advanced Chart

Key Stats

Today's Range
$58.70
$58.70
50-Day Range
$58.70
$59.28
52-Week Range
$27.30
$64.41
Volume
N/A
Average Volume
2.76 million shs
Market Capitalization
$4.12 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mirati Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MRTX Stock News Headlines

Mirati Therapeutics Stock Price History
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.tc pixel
See More Headlines

MRTX Stock Analysis - Frequently Asked Questions

Mirati Therapeutics, Inc. (NASDAQ:MRTX) posted its quarterly earnings results on Monday, November, 6th. The biotechnology company reported ($2.49) earnings per share for the quarter, topping analysts' consensus estimates of ($2.83) by $0.34. Mirati Therapeutics's revenue for the quarter was up 203.7% compared to the same quarter last year.

The following companies are subsidiaries of Mirati Therapeutics: MethylGene, MethylGene Inc., and Mirati Therapeutics B.V..

Based on aggregate information from My MarketBeat watchlists, some other companies that Mirati Therapeutics investors own include American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH), Humana (HUM) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
11/06/2023
Today
8/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MRTX
CIK
1576263
Fax
N/A
Employees
587
Year Founded
2013

Profitability

EPS (Trailing Twelve Months)
($12.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$740.87 million
Net Margins
-1,900.65%
Pretax Margin
-1,899.99%
Return on Equity
-82.15%
Return on Assets
-67.82%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.54
Quick Ratio
7.40

Sales & Book Value

Annual Sales
$12.44 million
Price / Sales
331.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$17.31 per share
Price / Book
3.39

Miscellaneous

Outstanding Shares
70,150,000
Free Float
67,861,000
Market Cap
$4.12 billion
Optionable
Optionable
Beta
0.77

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:MRTX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners